1. [18F]FDG Uptake in Adipose Tissue Is Not Related to Inflammation in Type 2 Diabetes Mellitus

   Reijrink, M., de Boer, S. A., Antunes, I. F., Spoor, D. S., Heerspink, H. J. L., Lodewijk, M. E., Mastik, M. F., Boellaard, R., Greuter, M. J. W., Benjamens, S., Borra, R. J. H., Slart, R. H. J. A., Hillebrands, J-L. & Mulder, D. J., 4-Sep-2020, In : Molecular Imaging and Biology.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL

   Idzerda, N. M. A., Clegg, L. E., Hernandez, A. F., Bakris, G., Penland, R. C., Boulton, D. W., Bethel, M. A., Holman, R. R. & Heerspink, H. J. L., May-2020, In : Diabetes obesity & metabolism. 22, 5, p. 798-806 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c

   Cannon, C. P., Perkovic, V., Agarwal, R., Baldassarre, J., Bakris, G., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Heerspink, H. J. L., Jardine, M. J., Levin, A., Li, J-W., Neal, B., Pollock, C., Wheeler, D. C., Zhang, H., Zinman, B. & Mahaffey, K. W., 4-Feb-2020, In : Circulation. 141, 5, p. 407-410 4 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

4. Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

   DAPA-CKD Investigators, Heerspink, H. J. L., Stefansson, B., Chertow, G. M., Correa-Rotter, R., Greene, T., Hou, F-F., Lindberg, M., McMurray, J., Rossing, P., Toto, R., Langkilde, A. M. & Wheeler, D. C., Feb-2020, In : Nephrology Dialysis Transplantation. 35, 2, p. 274-282 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Atrasentan in patients with diabetes and chronic kidney disease reply

   Heerspink, H. J. L., Parving, H-H. & de Zeeuw, D., 25-Jan-2020, In : LANCET. 395, 10220, p. 270-270 1 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

View all (305) »

1. Pills for protecting kidneys to reduce need of dialysis

   Hiddo Lambers Heerspink

   17/09/2019

   1 item of Media coverage

   Press/Media: Public Engagement Activities › Popular

View all (1) »

1. Asian-Australian Diabetes Meeting

   Hiddo Lambers Heerspink (Invited speaker)

   24-Aug-2019

   Activity: Participating in or organising an event › Participation in conference › Academic

2. European Association for the Study of Diabetes (EASD) Barcelona 2019

   Hiddo Lambers Heerspink (Invited speaker)

   17-Sep-2019

   Activity: Participating in or organising an event › Participation in conference › Academic

3. ASN Kidney week

   Hiddo Lambers Heerspink (Speaker)

   7-Nov-2019 → 9-Nov-2019

   Activity: Talk or presentation › Academic

View all (16) »